Business Context and Reporting Period
Company: The Kroger Co.
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Second quarter ended August 15, 2026 (and the two quarters ended August 15, 2026).
Business Overview: Kroger operates supermarkets, multi-department stores, and fulfillment centers across the United States. The company reports a single retail operations segment.
Key Financial Metrics
| Metric | Q2 2026 | Q2 2025 | YTD 2026 (2 Qtrs) | YTD 2025 (2 Qtrs) |
|---|---|---|---|---|
| Sales | $34,621 million | $33,940 million | $80,742 million | $79,058 million |
| Operating Profit | $971 million | $863 million | $2,378 million | $2,185 million |
| Net Earnings (Kroger Co.) | $641 million | $609 million | $1,543 million | $1,475 million |
| Diluted EPS | $1.05 | $0.91 | $2.51 | $2.20 |
| Operating Cash Flow (YTD) | $3,085 million (vs. $3,688 million YTD 2025) | |||
| Total Debt (Aug 15, 2026) | $17.0 billion (Current: $1.8B; Long-term: $15.2B) | |||
| Cash & Investments | $1.7 billion (Aug 15, 2026) |
Material Changes vs. Prior Period
- Sales Growth: Total sales increased 2.0% in Q2 2026 and 2.1% YTD, driven primarily by a 25.6% increase in fuel sales (due to higher retail fuel prices) and a 0.2% increase in identical sales excluding fuel.
- Profitability: Operating profit rose 12.5% in Q2 and 8.8% YTD. Operating margin improved to 2.80% in Q2 2026 from 2.54% in Q2 2025, aided by lower LIFO charges and reduced depreciation/amortization.
- EPS Growth: Diluted EPS increased 15.4% in Q2 and 14.1% YTD, benefiting from lower share counts due to aggressive buybacks and improved operating margins.
- Adjusted Metrics: Adjusted net earnings per diluted share increased 4.8% in Q2 and 5.5% YTD, excluding items such as transformation costs, merger litigation charges, and investment gains.
Guidance, Outlook, and Risks
- Acquisition Activity: On July 1, 2026, Kroger announced an agreement to acquire Giant Eagle, Inc. for approximately $1.65 billion ($1.25 billion cash + $400 million debt). The transaction is expected to close in fiscal 2027, subject to regulatory approval and divestitures.
- Capital Allocation: The company repurchased $1.3 billion of common stock in the first two quarters of 2026. As of August 15, 2026, $801 million remained under the December 2025 repurchase program. Dividends were increased to $0.39 per share in Q2 2026.
- Litigation Risks:
- Albertsons Merger: The terminated merger with Albertsons remains in litigation. Albertsons is seeking a $600 million termination fee; Kroger has filed counterclaims. Trial is scheduled for October 19, 2026.
- Opioid Settlements: Kroger has finalized settlements with states and Native American tribes totaling up to $1,236 million over 11 years. Approximately $978 million of this liability is recorded on the balance sheet as of August 15, 2026.
- Operational Headwinds: Identical sales growth was offset by the Inflation Reduction Act (pharmacy pricing), a shift to generic prescriptions, and the Cyclospora outbreak. eCommerce sales grew 14% in Q2, driven by delivery solutions.
Investor Verification Checklist
- Albertsons Litigation Outcome: Monitor the October 2026 trial regarding the $600 million termination fee and counterclaims.
- Giant Eagle Acquisition: Verify regulatory clearance status and potential divestiture requirements for the $1.65 billion deal.
- Opioid Liability: Track ongoing payments and potential additional litigation from non-participating jurisdictions.
- Pharmacy Margins: Assess the long-term impact of the Inflation Reduction Act and generic prescription shifts on pharmacy profitability.
- Capital Expenditures: Review the $2.7 billion YTD capital investment pace and its alignment with the "relatively consistent" annual guidance.